ArticleMolecular and cellular biochemistry2023

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.

Dylan Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.